Blog – Page 2 – Katalyst Wealth

[Stock idea]: Arrow Greentech – This small-cap dissolves plastic waste — and earns 34% EBITDA margins

May 5, 2026

Today I want to introduce you to a company that most investors haven’t heard of — Arrow Greentech Ltd. (BSE: 516064 | NSE: ARROWGREEN). It’s a niche specialty materials company with an interesting combination of a high-margin core business, a fast-growing green segment, and a patent-backed intellectual property portfolio. Here’s a quick overview, but before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst…

5 investing lessons that saved me ₹lakhs (and I learned it the hard way)

April 30, 2026

Seventeen years of investing teaches you things no textbook can. Some of these lessons cost money to learn. Some took years to fully sink in. A few I’m still working on. Here are my 5 most important investing lessons — and they may be different from yours. But, before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst Wealth. Important updates on New…

[Stock idea]: All E Technologies – Microsoft grew 28%. Their #1 partner grew 1.5%. Here’s why that gap may close

April 28, 2026

All E Technologies (ALLETEC) held its Q3 FY26 earnings call recently, and the central tension was impossible to miss — Microsoft is booming, yet Alletec’s growth has been near-flat for 4–5 quarters. Management had answers worth hearing. Here are the key takeaways, But, before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst Wealth. Important updates on New recommendations On, 19th Apr’26, we…

[Stock idea]: Alivus Life Sciences – This API company just hit its highest-ever margins — here’s what management said 👇

April 21, 2026

Alivus is executing well on the things it controls — margins, cash generation, and non-GPL growth. The CDMO recovery in Q3 was the key positive surprise. The stock’s longer-term re-rating will hinge on how quickly the high-potency API pipeline and Solapur ramp up. Management is conservative but credible. Here are the key takeaways, But, before that: Help us grow: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst…